Nexxt Spine completed enrollment and 6-month clinical data collection comparing the NEXXT MATRIXX® 3-D Printed titanium interbody family to Poly-Ether-Ether-Ketone (PEEK) devices.
NEXXT MATRIXX is manufactured with NEXXT Spine’s proprietary technology of intentionally engineered 3D laser printed titanium devices.
Nexxt Spine President, Andy Elsbury, said, “Nexxt Spine is grateful to physician researchers at The Ohio State University Wexner Medical Center for their time and effort in completing the 6 month review of the study results, and looks forward to the final 1 year data review.”
“Results from the 6 month data that was shared with Nexxt Spine demonstrated a significant increase in the fusion rates for both one and two level procedures, as compared to PEEK, (82% versus 25% for the PEEK device). In addition, the analysis of subsidence of the interbody devices had only 11.8% of levels for the NEXXT MATRIXX device showing subsidence greater than 2mm, while the PEEK device exhibited 55% of levels, showing that the NEXXT MATRIXX technology has intrinsic benefits to patients and their outcomes,” said Jim Freid, Director of Development and Clinical Studies.
Nexxt Spine completed enrollment and 6-month clinical data collection comparing the NEXXT MATRIXX® 3-D Printed titanium interbody family to Poly-Ether-Ether-Ketone (PEEK) devices.
NEXXT MATRIXX is manufactured with NEXXT Spine's proprietary technology of intentionally engineered 3D laser printed titanium devices.
Nexxt Spine President, Andy...
Nexxt Spine completed enrollment and 6-month clinical data collection comparing the NEXXT MATRIXX® 3-D Printed titanium interbody family to Poly-Ether-Ether-Ketone (PEEK) devices.
NEXXT MATRIXX is manufactured with NEXXT Spine’s proprietary technology of intentionally engineered 3D laser printed titanium devices.
Nexxt Spine President, Andy Elsbury, said, “Nexxt Spine is grateful to physician researchers at The Ohio State University Wexner Medical Center for their time and effort in completing the 6 month review of the study results, and looks forward to the final 1 year data review.”
“Results from the 6 month data that was shared with Nexxt Spine demonstrated a significant increase in the fusion rates for both one and two level procedures, as compared to PEEK, (82% versus 25% for the PEEK device). In addition, the analysis of subsidence of the interbody devices had only 11.8% of levels for the NEXXT MATRIXX device showing subsidence greater than 2mm, while the PEEK device exhibited 55% of levels, showing that the NEXXT MATRIXX technology has intrinsic benefits to patients and their outcomes,” said Jim Freid, Director of Development and Clinical Studies.
Copy to clipboard 
